Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 3.6 EX-3.6
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.4 EX-4.4
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.25 EX-10.25
- 10.26 EX-10.26
- 10.27 EX-10.27
- 10.28 EX-10.28
- 10.29 EX-10.29
- 10.30 EX-10.30
- 16.1 EX-16.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
AXNX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Axonics Modulation Technologies, Inc.
Irvine, California
We hereby consent to the use in the prospectus constituting a part of this registration statement of our report dated October 5, 2018, relating to the consolidated financial statements of Axonics Modulation Technologies, Inc., which is contained in that prospectus.
We also consent to the reference to us under the caption “Experts” in the prospectus.
/s/ BDO USA, LLP
Costa Mesa, California
October 5, 2018